TLRY

Tilray Brands, Inc. Common Stock

7.58

USD

TLRY Earnings Reports

Positive Surprise Ratio

TLRY beat 5 of 19 last estimates.

26%

Next Report

Date of Next Report

Apr 06, 2026

Estimate for Q3 26 (Revenue/ EPS)

$205.38M

-$0.14

Implied change from Q2 26 (Revenue/ EPS)

-5.58%

-65.85%

Implied change from Q3 25 (Revenue/ EPS)

+10.55%

-85.42%

Tilray Brands, Inc. Common Stock earnings per share and revenue

On Jan 08, 2026, TLRY reported earnings of -0.41 USD per share (EPS) for Q2 26, missing the estimate of -0.20 USD, resulting in a -100.98% surprise. Revenue reached 217.51 million, compared to an expected 215.17 million, with a 1.09% difference. The market reacted with a +0.55% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 205.38 million USD, implying an decrease of -65.85% EPS, and decrease of -5.58% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Phibro Animal Health Corporation Class A

Report Date

Feb 04, 2026 For Q2 26

Estimate

$0.68

Actual

$0.87

Surprise

+27.30%

Canopy Growth Corporation Common Shares

Report Date

Feb 06, 2026 For Q3 26

Estimate

-$0.04

Actual

-$0.13

Surprise

-198.00%

Aurora Cannabis Inc. Common Shares

Report Date

Feb 04, 2026 For Q3 26

Estimate

$0.21

Actual

$0.12

Surprise

-42.72%

High Tide Inc. Common Shares

Report Date

Jan 29, 2026 For Q4 25

Estimate

$0.00

Actual

-$0.56

Surprise

0.00%

Stryker Corporation

Report Date

Jan 29, 2026 For Q4 25

Estimate

$4.43

Actual

$4.47

Surprise

+0.69%

Boston Scientific Corp.

Report Date

Feb 04, 2026 For Q4 25

Estimate

$0.78

Actual

$0.80

Surprise

+1.61%

ResMed Inc.

Report Date

Jan 29, 2026 For Q2 26

Estimate

$2.75

Actual

$2.81

Surprise

+2.15%

GE HealthCare Technologies Inc. Common Stock

Report Date

Feb 04, 2026 For Q4 25

Estimate

$1.42

Actual

$1.44

Surprise

+0.96%

Envista Holdings Corporation Common stock, $0.01 par value per share

Report Date

Feb 05, 2026 For Q4 25

Estimate

$0.32

Actual

$0.38

Surprise

+15.43%

Prestige Consumer Healthcare Inc.

Report Date

Feb 05, 2026 For Q3 26

Estimate

$1.15

Actual

$1.13

Surprise

-1.36%

FAQ

What were Tilray Brands, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Tilray Brands, Inc. Common Stock reported EPS of -$0.41, missing estimates by -100.98%, and revenue of $217.51M, 1.09% above expectations.

How did the market react to Tilray Brands, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 0.55%, changed from $9.13 before the earnings release to $9.18 the day after.

When is Tilray Brands, Inc. Common Stock expected to report next?

The next earning report is scheduled for Apr 06, 2026.

What are the forecasts for Tilray Brands, Inc. Common Stock's next earnings report?

Based on 7 analysts, Tilray Brands, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $205.38M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.